KRMD (KORU Medical Systems) ROCE %: -17.41% (As of Mar. 2026)

What is KORU Medical Systems ROCE %?

KORU Medical Systems KRMD -3.27% 76 ROCE % is -17.41% as of Mar. 2026. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. KORU Medical Systems's annualized ROCE % for the quarter that ended in Mar. 2026 was -17.41%.

KORU Medical Systems (NAS:KRMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

KORU Medical Systems ROCE % Related Terms

KORU Medical Systems ROCE % Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems ROCE % Chart

KORU Medical Systems Annual Data

Trend

Feb16

Feb17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-19.33

-30.00

-34.59

-29.28

-14.85

KORU Medical Systems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-25.26	-6.44	-17.93	-11.14	-17.41

76GF Score

KORU Medical Systems Inc KRMD

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

KORU Medical Systems ROCE % Calculation

KORU Medical Systems's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-2.972	/	( ( (27.219 - 7.202)	+	(28.2 - 8.194) )	/ 2 )
	=	-2.972	/	( (20.017	+	20.006)	/ 2 )
	=	-2.972	/	20.0115
	=	-14.85 %

KORU Medical Systems's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-3.46	/	( ( (28.2 - 8.194)	+	(28.592 - 8.852) )	/ 2 )
	=	-3.46	/	( ( 20.006	+	19.74 )	/ 2 )
	=	-3.46	/	19.873
	=	-17.41 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -17.41% mean?

KORU Medical Systems (KRMD) has a ROCE % of -17.41% as of Mar. 2026.

Is KORU Medical Systems' ROCE % too high?

KORU Medical Systems' current ROCE % is -17.41%. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does KORU Medical Systems' ROCE % compare to EMBC and PDEX?

KORU Medical Systems' ROCE % of -17.41% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current ROCE % is -17.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is KORU Medical Systems stock overvalued right now?

Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.44 — trading 8.8% above its estimated fair value. The current ROCE % is -17.41%. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current ROCE % is -17.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.44 is trading 8.8% above its estimated GF Value™ of $4.08. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

ROCE %: -17.41%
GF Value™: $4.08 vs. price of $4.44 (8.8% above fair value)
GF Score™: 76/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KORU Medical Systems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies EMBC PDEX SMTI UTMD STXS MBOT OSUR POCI DXR NEPH ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430

Website https://www.korumedical.com

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

76GF Score

Get the complete analysis for KRMD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.44

Price

$4.08

GF Value

View KRMD Analysis

See ROCE % data for all stocks →